Mutations in HNRNPH2 that disrupt the nuclear localization signal (NLS) of the hnRNPH2 protein are associated with a neurodevelopmental disorder (NDD) characterized by intellectual disability, motor and language delays, growth and musculoskeletal dysmorphias, and epilepsy (1–3). Here, HNRNPH2 is linked to epilepsy.